Our drug doubles the clinical efficacy rate of injections for low back pain. $2B revenue potential for lead drug . Platform tech with multiple opportunities.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free